Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms

키워드

참고문헌 (91)

1. Koo H, "Targeting microbial biofilms : current and prospective therapeutic strategies", Nat. Rev. Microbiol, 15, pp.740~755 (2017)
2. Flemming H-C, "Biofilms : an emergent form of bacterial life", Nat. Rev. Microbiol, 14, pp.563~575 (2016)
3. de Vos WM, "Microbial biofilms and the human intestinal microbiome", Npj Biofilms Microbiomes, 1, pp.15005~ (2015)
4. Percival SL, "Healthcare-associated infections, medical devices and biofilms : risk, tolerance and control", J. Med. Microbiol, 64, pp.323~334 (2015)
5. Miquel S, "Anti-biofilm activity as a health issue", Front. Microbiol, 7, pp.592~ (2016)
6. Lebeaux D, "Biofilm-related infections : bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics", Microbiol. Mol. Biol. Rev, 78, pp.510~543 (2014)
7. Delcaru C, "Microbial biofilms in urinary tract infections and prostatitis : etiology, pathogenicity, and combating strategies", Pathogens, 5, pp.65~ (2016)
8. Hobley L, "Giving structure to the biofilm matrix : an overview of individual strategies and emerging common themes", FEMS Microbiol. Rev, 39, pp.649~669 (2015)
9. Flemming HC, "The biofilm matrix", Nat. Rev. Microbiol, 8, pp.623~633 (2010)
10. Jana S, "Nonlinear rheological characteristics of single species bacterial biofilms", NPJ Biofilms Microbiomes, 6, pp.19~ (2020)
11. Bak G, "Identification of novel sRNAs involved in biofilm formation, motility and fimbriae formation in Escherichia coli", Sci. Rep, 5, pp.15287~ (2015)
12. Ribet D, "How bacterial pathogens colonize their hosts and invade deeper tissues", Microbes Infect, 17, pp.173~183 (2015)
13. Ligthart K, "Bridging bacteria and the gut : functional aspects of type iv pili", Trends Microbiol, 28, pp.340~348 (2020)
14. Papenfort K, "Quorum sensing signal-response systems in Gram-negative bacteria", Nat. Rev. Microbiol, 14, pp.576~588 (2016)
15. Hazan Z, "Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves", Antimicrob. Agents Chemother, 50, pp.4144~4152 (2006)
16. Limoli DH, "Bacterial extracellular polysaccharides in biofilm formation and function", Microbiol. Spectr, 3, pp.10~ (2015)[DOI]
17. Jamal M, "Bacterial biofilm and associated infections", J. Chin. Med. Assoc, 81, pp.7~11 (2018)
18. Wannigama DL, "Simple fluorometric-based assay of antibiotic effectiveness for Acinetobacter baumannii biofilms", Sci. Rep, 9, pp.6300~ (2019)
19. Nandakumar V, "Characteristics of bacterial biofilm associated with implant material in clinical practice", Polymer J, 45, pp.137~142 (2012)
20. Hathroubi S, "Biofilms : microbial shelters against antibiotics", Microb. Drug Resist, 23, pp.147~156 (2017)
21. Yin W, "Biofilms : the microbial"protective clothing"in extreme environments", Int. J. Mol. Sci, 20, pp.3423~ (2019)
22. Tseng BS, "The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin", Environ. Microbiol, 15, pp.2865~2878 (2013)
23. Zhou G, "The three bacterial lines of defense against antimicrobial agents", Int. J. Mol. Sci, 16, pp.21711~21733 (2015)
24. Sharma D, "Antibiotics versus biofilm : an emerging battleground in microbial communities", Antimicrob. Resist. Infect. Control, 8, pp.76~ (2019)
25. Stewart PS, "Reaction–diffusion theory explains hypoxia and heterogeneous growth within microbial biofilms associated with chronic infections", Npj Biofilms Microbiomes, 2, pp.16012~ (2016)
26. Singh S, "Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents", Open Microbiol. J, 11, pp.53~62 (2017)
27. Miao Y, "In vitro adsorption revealing an apparent strong interaction between endophyte Pantoea agglomerans YS19 and host rice", Curr. Microbiol, 57, pp.547~551 (2008)
28. Li Q, "SPM43.1 contributes to acid-resistance of non-symplasmata-forming cells in Pantoea agglomerans YS19", Curr. Microbiol, 64, pp.214~221 (2012)
29. Zhao X, "Quorum-sensing regulation of antimicrobial resistance in bacteria", Microorganisms, 8, pp.425~ (2020)
30. Passos da Silva D, "An update on the sociomicrobiology of quorum sensing in gramnegative biofilm development", Pathogens, 6, pp.51~ (2017)
31. Rutherford ST, "Bacterial quorum sensing : its role in virulence and possibilities for its control", Cold Spring Harb. Perspect. Med, 2, pp.a012427~ (2012)
32. Whiteley M, "Progress in and promise of bacterial quorum sensing research", Nature, 551, pp.313~320 (2017)
33. Wolska KI, "Genetic control of bacterial biofilms", J. Appl. Genet, 57, pp.225~238 (2016)
34. Blanco P, "Bacterial multidrug efflux pumps : Much more than antibiotic resistance determinants", Microorganisms, 4, pp.14~ (2016)
35. Pena RT, "Relationship between quorum sensing and secretion systems", Front. Microbiol, 10, pp.1100~ (2019)
36. Qian G, "Proteomic analysis reveals novel extracellular virulence-associated proteins and functions regulated by the diffusible signal factor (DSF) in Xanthomonas oryzae pv. oryzicola", J. Proteome Res, 12, pp.3327~3341 (2013)
37. Jiang Q, "Quorum sensing : a prospective therapeutic target for bacterial diseases", Biomed. Res. Int, 2019, pp.2015978~ (2019)
38. Hu M, "Indole affects biofilm formation in bacteria", Indian J. Microbiol, 50, pp.362~368 (2010)
39. Yaikhan T, "Indole and derivatives modulate biofilm formation and antibiotic tolerance of Klebsiella pneumoniae", Indian J. Microbiol, 59, pp.460~467 (2019)
40. Abisado RG, "Bacterial quorum sensing and microbial community interactions", mBio, 9, pp.e02331~17 (2018)
41. Zhang J-W, "AidB, a novel thermostable n-acylhomoserine lactonase from the Bacterium Bosea sp", Appl. Environ. Microbiol, 85, pp.e02065~02019 (2019)
42. Blöcher R, "Design, synthesis, and evaluation of alkyl-quinoxalin-2(1h)-one derivatives as anti-quorum sensing molecules, inhibiting biofilm formation in Aeromonas caviae Sch3", Molecules, 23, pp.3075~ (2018)
43. Wei Q, "Chinese medicinal herb extract inhibits PQS-mediated quorum sensing system in Pseudomonas aeruginosa", J. Ethnopharmacol, 248, pp.112272~ (2020)
44. Van Acker H, "The role of efflux and physiological adaptation in biofilm tolerance and resistance", J. Biol. Chem, 291, pp.12565~12572 (2016)
45. Zhang L, "Involvement of a novel efflux system in biofilm-specific resistance to antibiotics", J. Bacteriol, 190, pp.4447~4452 (2008)
46. Ferrer-Espada R, "A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains", Sci. Rep, 9, pp.3452~ (2019)
47. Liao J, "The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms", J. Bacteriol, 195, pp.3352~3363 (2013)
48. Kim J, "Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm", Antimicrob. Agents Chemother, 52, pp.1446~1453 (2008)
49. Alcalde-Rico M, "Role of the multidrug resistance efflux pump MexCD-OprJ in the Pseudomonas aeruginosa quorum sensing response", Front. Microbiol, 9, pp.2752~ (2018)
50. Alcalde-Rico M, "The analysis of the role of MexAB-OprM on quorum sensing homeostasis shows that the apparent redundancy of Pseudomonas aeruginosa multidrug efflux pumps allows keeping the robustness and the plasticity of this intercellular signaling network", bioRxiv. 2020.2003.2010.986737., ~ (2020)
51. He N, "Enhancement of vancomycin activity against biofilms by using ultrasoundtargeted microbubble destruction", Antimicrob. Agents Chemother, 55, pp.5331~5337 (2011)
52. Harrison-Balestra C, "A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy", Dermatol. Surg, 29, pp.631~635 (2003)
53. Wolcott RD, "Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window", J. Wound Care, 19, pp.320~328 (2010)
54. Vuotto C, "Novel treatment strategies for biofilm-based infections", Drugs, 79, pp.1635~1655 (2019)
55. Gunn JS, "What's on the outside matters : the role of the extracellular polymeric substance of gramnegative biofilms in evading host immunity and as a target for therapeutic intervention", J. Biol. Chem, 291, pp.12538~12546 (2016)
56. Peng X, "Cyclic di-AMP mediates biofilm formation", Mol. Microbiol, 99, pp.945~959 (2016)
57. Ren Z, "Molecule targeting glucosyltransferase inhibits Streptococcus mutans biofilm formation and virulence", Antimicrob. Agents Chemother, 60, pp.126~135 (2016)
58. Qvortrup K, "Small molecule anti-biofilm agents developed on the basis of mechanistic understanding of biofilm formation", Front. Chem, 7, pp.742~ (2019)
59. Kaplan JB, "Biofilm matrix-degrading enzymes", Methods Mol. Biol, 1147, pp.203~213 (2014)
60. Fleming D, "Glycoside hydrolases degrade polymicrobial bacterial biofilms in wounds", Antimicrob. Agents Chemother, 61, pp.e01998~16 (2017)
61. Iwase T, "Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization", Nature, 465, pp.346~349 (2010)
62. Okshevsky M, "Extracellular DNA as a target for biofilm control", Curr. Opin. Biotechnol, 33, pp.73~80 (2015)
63. Hymes SR, "DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo", J. Infect. Dis, 207, pp.1491~1497 (2013)
64. Baelo A, "Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections", J. Control. Release, 209, pp.150~158 (2015)
65. Brackman G, "Quorum sensing inhibitors as anti-biofilm agents", Curr. Pharm. Des, 21, pp.5~11 (2015)
66. Kalia M, "Designing quorum sensing inhibitors of Pseudomonas aeruginosa utilizing FabI : an enzymic drug target from fatty acid synthesis pathway", 3 Biotech, 9, pp.40~ (2019)
67. Zhang J, "Heterologous expression of the marine-derived quorum quenching enzyme moml can expand the antibacterial spectrum of Bacillus brevis", Mar. Drugs, 17, pp.128~ (2019)
68. Luo J, "Baicalin inhibits biofilm formation, attenuates the quorum sensingcontrolled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model", PLoS One, 12, pp.e0176883~ (2017)
69. Sun B, "Analysis of the antibacterial effect of an Edwardsiella tarda LuxS inhibitor", Springerplus, 5, pp.92~92 (2016)
70. McBrayer DN, "Development and utilization of peptide-based quorum sensing modulators in Grampositive bacteria", Org. Biomol. Chem, 18, pp.7273~7290 (2020)
71. de la Fuente-Nunez C, "Synthetic antibiofilm peptides", Biochim. Biophys. Acta, 1858, pp.1061~1069 (2016)
72. Asfour HZ, "Anti-quorum sensing natural compounds", J. Microsc. Ultrastruct, 6, pp.1~10 (2018)
73. Paul D, "Nature to the natural rescue : silencing microbial chats", Chem. Biol. Interact, 280, pp.86~98 (2018)
74. Defoirdt T, "Quorum-sensing systems as targets for antivirulence therapy", Trends Microbiol, 26, pp.313~328 (2018)
75. Donlan RM, "Preventing biofilms of clinically relevant organisms using bacteriophage", Trends Microbiol, 17, pp.66~72 (2009)
76. Jamal M, "Characterization of Siphoviridae phage Z and studying its efficacy against multidrugresistant Klebsiella pneumoniae planktonic cells and biofilm", J. Med. Microbiol, 64, pp.454~462 (2015)
77. O'Flaherty S, "Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals", Appl. Environ. Microbiol, 71, pp.1836~1842 (2005)
78. Cerca N, "Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K", Lett. Appl. Microbiol, 45, pp.313~317 (2007)
79. Chan BK, "Bacteriophages and their enzymes in biofilm control", Curr. Pharm. Des, 21, pp.85~99 (2015)
80. Abedon ST, "Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections", Adv. Drug Deliv. Rev, 145, pp.18~39 (2019)
81. Lee NY, "Nanoparticles in the treatment of infections caused by multidrug-resistant organisms", Front. Pharmacol, 10, pp.1153~ (2019)
82. Hetrick EM, "Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles", Biomaterials, 30, pp.2782~2789 (2009)
83. Rai MK, "Silver nanoparticles : the powerful nanoweapon against multidrug-resistant bacteria", J. Appl. Microbiol, 112, pp.841~852 (2012)
84. Caubet R, "A radio frequency electric current enhances antibiotic efficacy against bacterial biofilms", Antimicrob. Agents Chemother, 48, pp.4662~4664 (2004)
85. Niepa THR, "Eradication of Pseudomonas aeruginosa cells by cathodic electrochemical currents delivered with graphite electrodes", Acta Biomater, 50, pp.344~352 (2017)
86. Dusane DH, "Electroceutical treatment of Pseudomonas aeruginosa biofilms", Sci. Rep, 9, pp.2008~ (2019)
87. Tursi SA, "Salmonella Typhimurium biofilm disruption by a human antibody that binds a pan-amyloid epitope on curli", Nat. Commun, 11, pp.1007~ (2020)
88. Rasko DA, "Anti-virulence strategies to combat bacteria-mediated disease", Nat. Rev. Drug Discov, 9, pp.117~128 (2010)
89. Ghosh A, "Small-molecule inhibition of bacterial biofilm", ACS Omega, 5, pp.3108~3115 (2020)
90. Cavalheiro M, "Candida biofilms : threats, challenges, and promising Strategies", Front. Med. (Lausanne), 5, pp.28~ (2018)
91. Verderosa AD, "Bacterial biofilm eradication agents : a current review", Front. Chem, 7, pp.824~ (2019)

관련 논문AI추천